International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

Comparative Study of Chemotherapy Tolerance and Immune Function Changes in Gynecological Malignancy Patients with HIV ...

Key points A 69-year-old man presented to the emergency department with several months of progressive weakness, exertional dyspnea, and recurrent sinopulmonary infections. Over the preceding 6 months, ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection. It gradually destroys brain tissue ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

Brain cells that promote tumor expansion for aggressive cancers such as glioblastoma can be “flipped” to instead inhibit that ...

A DNA scaffold that carries HIV vaccine proteins into the body sharpens the immune response against the virus.

Switching to a 2-drug ART regimen was highly effective and well tolerated in virologically suppressed patients with HIV.

Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...